The Founder's Guide to

Ascenta Capital

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Ascenta Capital is a biotechnology investment firm based in the United States, managing $335 million in assets. Founded to support companies advancing clinical development, it focuses on concentrated investments in biotech firms transitioning from preclinical to early human trials. The firm has a portfolio of 8 companies.

Learn More

Frequently Asked Questions

Does Ascenta Capital lead rounds?

Ascenta Capital often leads investment rounds, particularly in early-stage biotech companies where they can provide significant support and guidance.

What is Ascenta Capital's stance on follow-on investments?

The firm is open to follow-on investments, especially for companies that demonstrate strong progress in their clinical development and align with their patient-centered approach.

How large is Ascenta Capital's current fund?

Ascenta Capital manages a fund size of $335 million, which they allocate towards concentrated investments in biotech firms.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.